KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Gains from Investment Securities (2018 - 2025)

Historic Gains from Investment Securities for Guardant Health (GH) over the last 8 years, with Q3 2025 value amounting to $2.3 million.

  • Guardant Health's Gains from Investment Securities fell 2119.0% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.2 million, marking a year-over-year increase of 20909.43%. This contributed to the annual value of $15.7 million for FY2024, which is 4004.64% up from last year.
  • As of Q3 2025, Guardant Health's Gains from Investment Securities stood at $2.3 million, which was down 2119.0% from $7.4 million recorded in Q2 2025.
  • Guardant Health's Gains from Investment Securities' 5-year high stood at $170.8 million during Q1 2021, with a 5-year trough of $64000.0 in Q2 2021.
  • In the last 5 years, Guardant Health's Gains from Investment Securities had a median value of $2.9 million in 2024 and averaged $12.2 million.
  • Over the last 5 years, Guardant Health's Gains from Investment Securities had its largest YoY gain of 863004.6% in 2021, and its largest YoY loss of 9932.03% in 2021.
  • Guardant Health's Gains from Investment Securities (Quarter) stood at $314000.0 in 2021, then soared by 332.8% to $1.4 million in 2022, then skyrocketed by 127.01% to $3.1 million in 2023, then surged by 160.06% to $8.0 million in 2024, then plummeted by 71.77% to $2.3 million in 2025.
  • Its Gains from Investment Securities stands at $2.3 million for Q3 2025, versus $7.4 million for Q2 2025 and $15.5 million for Q1 2025.